Citizens' Groups Protest Use
of Weapons-Grade Uranium
at Chalk River Isotope Facility

Maple Reactors and Weapons-Grade Uranium


INDEX


P R E S S   R E L E A S E

Concerned Citizens of Renfrew County and Area

P.O. Box 981, Pembroke, Ontario K8A 7M5
Tel. : (613) 735-4876 Fax: (613) 735-6444


For immediate release

Pembroke, Ontario,
August 12, 1999

Concerned Citizens of Renfrew County and Area (CCRC) wants the Atomic Energy Control Board (AECB) not to grant a licence to a controversial nuclear project consisting of two nuclear reactors and a medical isotope processing facility being built at the Chalk River Laboratories of Atomic Energy of Canada, Limited (AECL).

The Board meets on Thursday, August 12, in Ottawa, to consider this and other matters. CCRC wants the AECB to carefully and thoroughly examine the environmental consequences of using weapons-grade uranium in the civilian project before addressing the licensing issue.

The $150 million complex, financed by Canadian taxpayers, will be owned by a private company, MDS/Nordion, and operated by AECL. The new facilities are designed to use 93.3 percent enriched uranium   [ 93.3 percent uranium-235 ]   which would have to be provided by a U.S. nuclear weapons facility.

93.3 percent enriched uranium is also known as "weapons-grade uranium". It is identical in composition to the uranium explosive in the Hiroshima bomb. Technically, it is described as "highly enriched uranium" or "HEU". On June 16 the U.S. Nuclear Regulatory Commission (NRC) held an extraordinary hearing to determine if export of 93.3 percent enriched uranium for the Chalk River project violates a legal requirement in the U.S. Atomic Energy Act to phase-out commercial use of highly enriched uranium (HEU). This requirement, known as the Schumer Amendment, is intended to reduce accessibility to weapons-usable nuclear materials as a way of inhibiting the proliferation of nuclear weapons worldwide. As a result of the American hearing, the Canadian project proponents must file annual reports, accessible to the public, on progress in converting the Canadian isotope-production facilities so they can use use low-enriched uranium   [ LEU, which is not weapons-usable ]   instead of HEU.

CCRC maintains Canadian authorities are ignoring the important issue of conversion away from the use of HEU. Furthermore, the group wants more consideration given to:

The group has written Dr. Agnes Bishop, AECB President, asking that an operating license for the project not be granted at the August 12 Board meeting.

Three other public interest groups, Canadian Coalition for Nuclear Responsibility, Campaign for Nuclear Phaseout, and the Nuclear Awareness Project have also written to the AECB urging a delay in licensing, citing a variety of concerns including unresolved safety issues, waste disposal issues and the need to convert to the use of LEU.

CCRC has requested that a comprehensive environmental assessment be carried out to address its concerns.

- 30 -

For more information contact:

Gordon Edwards

514-489-5118

Canadian Coalition for Nuclear Responsibility

Kristen Ostling

613-789-3634

Campaign for Nuclear Phaseout

Ole Hendrickson

613-735-4876

Concerned Citizens of Renfrew County

Irene Kock

905-852-3044

Nuclear Awareness Project


Submissions to the AECB on
the Licensing of the MMIR Project
(MDS/Nordion Medical Isotope Reactor Project)


1. SUBMISSION FROM CCRC

Concerned Citizens of Renfrew County and Area
P.O. Box 981, Pembroke, Ontario K8A 7M5
Tel. : (613) 735-4876   Fax: (613) 735-6444

July 22, 1999

Dr. Agnes Bishop
Atomic Energy Control Board (AECB)
280 Slater Street, P.O. Box 1046
Ottawa, ON K1P 5S9
fax: 613-995-5086

Dear Dr. Bishop:

Re: Operating license for MAPLE 1 and 2 Reactors, and New Processing Facility, MDS/Nordion Medical Isotope Reactor (MMIR) Project, Chalk River Laboratories (CRL), Atomic Energy of Canada Limited (AECL)

We would like to outline a number of reasons to delay the issuance of an operating license for the MMIR project, which will be considered at the August 12, 1999 Board meeting.

Board Management Documents 99-70 and 99-71, the most recent publicly available documents concerning this project, indicate that applicant's performance is fully acceptable on only 4 of 18 topics discussed by AECB staff. This fact alone indicates that the application is not ready for Board consideration.

The final paragraph in the Executive Summary of BMD 99-71 states,

In order to maintain the project's schedule, AECL has requested that the operating license be approved by August 1999.

Such comments from Board staff are not appropriate, and betray a continuing lack of independence between the AECB and the nuclear industry. The AECB is accountable to the public and its elected officials. An applicant's project schedule should not dictate the timing of licensing decisions.

As a public interest group, we do our best to ensure that human health, safety, and environmental considerations are fully addressed in matters coming before the Board. If an operating license for the MMIR Project is approved on August 12, 1999, we will have no further opportunities to review the applicant's performance and to ensure that public concerns are being adequately addressed.

Here are some topics of major public interest in BMD 99-70 for which resolution is needed prior to licensing:

These deficiencies have been most problematic for issues regarding the proposed use of highly-enriched uranium (HEU). As you may be aware, concerns have been raised that the export of HEU from the U.S. for the MMIR project violates the U.S. Atomic Energy Act. The Schumer Amendment, added to the Atomic Energy Act by the Energy Policy Act of 1992, imposes restrictions on U.S. exports of HEU. HEU targets can be exported only if:

On June 16, 1999, the U.S. Nuclear Regulatory Commission (NRC) held an extraordinary hearing on the application by MDS/Nordion and AECL to import 130 Kg of 93.3 percent enriched uranium for the MMIR project. As a result of that hearing, conditions (Appendix I) were imposed on the export license that require the applicants to submit yearly status reports to the NRC, detailing Canadian cooperation in developing LEU targets for the MAPLE reactors. These status reports will be public.

This action makes it all the more important that alternatives to the use of HEU in the MMIR project be publicly examined prior to licensing of its operations. The AECB, on behalf of Canada, should demonstrate a good faith effort to address nuclear proliferation concerns by taking effective actions within its competence to remove weapons-grade uranium from global commerce.

The understanding of the NRC is "that AECL will cooperate fully with ANL [Argonne National Laboratory, developer of the LEU target for the MAPLE reactors] to complete a feasibility study as soon as possible." The following passage from the NRC decision stresses the importance of quick action in this regard:

In light of these commitments, the Commission is encouraged that AECL may have a feasibility study in hand in time to consider whether minor modifications could be made prior to the MAPLE reactors and their processing facility coming on line that would permit the use of LEU targets, or take other reasonable measures that would at least preserve the opportunity to move to LEU targets in the future.

To ensure compliance with the Schumer Amendment, the Commission expects applicants to pursue all reasonable measures that would not cause ''a large percentage increase in the total cost of operating the reactor.''

We strongly urge the AECB to make the completion of this joint feasibility study a prerequisite for the issuance of an operating license for the MMIR project. We also urge the AECB to make annual public reports on progress in making the transition to use of LEU targets a license condition, parallel to that in the NRC decision.

These actions will not only serve the public interest, but will benefit the project proponents by helping ensure a continuing supply of U-235 targets for their manufacturing process.

Yours truly,


Ole Hendrickson, Researcher,
Concerned Citizens of Renfrew County and Area


2. SUBMISSION FROM NAP

Nuclear Awareness Project
P.O. Box 104, Uxbridge,
Ontario, Canada, L9P 1M6

July 22, 1999

It is apparent from a review of the Current AECB Board Member Documents relating to initial consideration of the licensing for the MAPLE reactors (99-70 series), that AECL is not ready to operate the MAPLE reactors. There were significant outstanding problems as of only 3 months ago. However, the time pressure surrounding this project has been extraordinary, and Nuclear Awareness Project is very concerned that the licensing process is bending too much to accommodate the push to start up the reactors.

Is it no longer true that the NRU is expected to run until 2005? Why the rush? [The NRU currently produces the same isotopes that the new reactors are designed to produce.] All 'conditionally acceptable' matters must be resolved prior to start-up of the reactors. [Board staff has identified a number of 'conditionally acceptable' issues related to the new reactors.]

Nuclear Awareness Project endorses the submission from Concerned Citizens of Renfrew County and Area (BMD 99-70.2) which formally requests that the Board undertake a 'comprehensive study' of the project under the Canadian Environmental Assessment Act. As was noted in our earlier submission on the 'screening' level review for this project, there are many compelling reasons to undertake a more thorough environmental assessment.

The following outstanding matters noted in BMD 99-70 are of particular concern to Nuclear Awareness Project:

High Enriched Uranium Targets - The Use of Bomb-Grade Uranium

The recent request by AECL and MDS to import high enriched uranium targets from the United States for use in the MAPLE reactors resulted in an important decision by the U.S. Nuclear Regulatory Commission. The approval to import these targets is conditional on proof of efforts to convert the reactors to use low enriched uranium targets instead.

At issue is compliance with a U.S. law -- the 1992 Schumer Amendment to the Energy Policy Act -- which restricts the export of high grade uranium and plutonium due to concerns about potential nuclear weapons proliferation. Ideally, conversion of the MAPLE reactors to use low enriched uranium should be undertaken prior to start-up of the reactors. Since AECL has scheduled closure of the NRU in 2005, this should provide sufficient time for the conversion.

The AECB should ensure that a licence condition clearly sets out a requirement for this conversion [to take place] prior to start-up. This matter is not discussed in BMD 99-70. It took an intervention by a U.S. non-governmental organization, the Nuclear Control Institute, at a U.S. Nuclear Regulatory Commission hearing, before AECL and MDS Nordion even agreed to commit to converting the MAPLE reactors to low enriched uranium.

The AECB should not have provided design approval for use of high enriched uranium in the first place, given the nuclear weapons proliferation risks involved with commerce in high enriched uranium. The import of high enriched uranium into Canada sets a dangerous precedent for global trade in nuclear bomb-grade materials, including uranium and plutonium.

Irene Kock
Nuclear Awareness Project
P.O. Box 104, Uxbridge, Ontario, Canada, L9P 1M6


3. SUBMISSION FROM CCNR

Canadian Coalition for Nuclear Responsibility
PO Box 236, Succursale "Snowdon",
Montreal, Quebec, H3X 3T4
Tel. and Fax : (514) 489-5118

July 22, 1999

Dr. Agnes Bishop, President
Atomic Energy Control Board (AECB)
280 Slater Street, P.O. Box 1046
Ottawa, ON K1P 5S9

fax: 613-995-5086 e-mail: ellyson.c@atomcon.gc.ca

Dear Dr. Bishop:

The Canadian Coalition for Nuclear Responsibility is opposed to the granting of a operating licence to the MDS/Nordion Medical Isotope Project.

Questions relating to the transfer and safeguarding of weapons-grade materials such as highly-enriched uranium and separated plutonium is, in our view, of the highest importance in matters of regulation affecting the nuclear industry. Historically, the very creation of the Atomic Energy Control Board by the Government of Canada and granting of exclusive jurisdiction over nuclear matters to AECB was largely motivated by such considerations.

To treat such matters lightly is hardly in the best interests of Canada or the world community. It would therefore be unacceptable to CCNR for AECB to grant a licence to the MDS/Nordion Medical Isotope Project without a full Comprehensive Study under the Canadian Environmental Assessment Act --one that would focus not only on the usual safety and environmental considerations of reactor operations, but also on:

CCNR is convinced that AECB must greatly expand its ability and its determination to examine licensing applications with non-proliferation concerns uppermost. In the past this has been largely academic, since shipments of weapons-grade material in Canada were not as routinely planned or as widely known. Neither Canada nor the nuclear industry can afford to be lax on this issue, since any breach of security could have the most far-reaching and grave consequences.

The easiest and most satisfactory way to ensure that non-proliferation objective are met is to avoid the use of weapons-grade material in the first place. Since AECL is required by American law to work toward the objective of eventually eliminating the use of HEU in MAPLE reactors, some effort on the part of AECB to determine whether or not the use of HEU could be completely bypassed would seem to be in order, in the interests of Canada and Canadians.

Hoping that AECB will not rush to grant a licence to this facility until the matters touched on here have been addressed in a thorough manner, I am

Yours very truly,


Gordon Edwards, Ph.D., President,
Canadian Coalition for Nuclear Responsibility
PO Box 236, Station Snowdon, Montreal, H3X 3T4

Appendix

Excerpt from the decision of the
U.S. Nuclear Regulatory Commission

October 30, 1998.

Transnuclear, Inc., as agent for Atomic Energy of Canada, Ltd. (AECL), filed License Application No. XSNM-03060 with the Commission, seeking authorization to export 130.65 kilograms of highly enriched uranium (HEU) containing 121.8966 kilograms of U-235 in the form of uranium dioxide (UO2) targets.

The HEU targets, to be shipped quarterly over a five-year period, would be irradiated to produce radioisotopes, in particular Mo-99 [molybdenum-99], for medical applications. The targets are to be irradiated in the MAPLE 1 and 2 reactors, currently in an advanced state of construction, and processed in a new facility at AECL's Chalk River Nuclear Laboratories. The MAPLE reactors and associated processing facility will be operated by AECL on behalf of MDS/Nordion.

The Schumer Amendment, added to the Atomic Energy Act by the Energy Policy Act of 1992, Pub. L. No. 102-486, 106 Stat. 2776 (1992), and subsequently codified in the Commission's regulations at 10 CFR 110.42(a)(9), imposes the following restrictions on exports of HEU fuel and targets:

    a. The Commission may issue a license for the export of high enriched uranium to be used as a fuel or target in a nuclear research or test reactor only if, in addition to any other requirements of this Act, the Commission determines that

    1. there is no alternative nuclear reactor fuel or target enriched in the isotope 235 to a lesser percent than the proposed export, that can be used in the reactor;

    2. the proposed recipient of that uranium has provided assurances that, whenever an alternative nuclear reactor fuel or target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and

    3. the United States Government is actively developing an alternative nuclear reactor fuel or target that can be used in that reactor.

III. ISSUANCE OF THE LICENSE

To ensure that the provisions of the Schumer Amendment continue to be met, the Commission directs that the five-year license be conditioned to require the Applicants to submit in writing to the Commission a yearly status report detailing the progress of the program and Canadian cooperation in developing LEU targets for the MAPLE reactors. The first report should be submitted 60 days prior to the first quarterly shipment that will take place after July 1, 2000. Thus, if a shipment is scheduled for July 4, 2000, the NRC should receive a status report no later than May 8, 2000. Further annual reports will be required no later than 365 days after the submission of the first annual report.

At the June 16 meeting, the Executive Branch offered to provide the Commission with a similar annual status report communicating the Executive Branch's views on the progress in development of LEU targets for the MAPLE reactors. The Commission accepts this offer and requests that the Executive Branch report be submitted to the Commission annually no later than 30 days after the submission of Applicants' report. The Executive Branch reports should include assurances that the funds necessary to develop the LEU targets in a timely manner have been made available to ANL.

The Commission intends to place both the Applicants' reports and the Executive Branch reports in the Public Document Room. Therefore, proprietary information should be handled as an annex to the reports so that the information can be easily segregated from the rest of the reports. Upon examination of the reports, the Commission may hold a public meeting, if necessary, to gather additional information. If the Commission should make a finding, following review of these periodic status reports and a public meeting, if necessary, that the requirements of the Schumer Amendment are not being met, the Commission may modify, suspend, or revoke the license pursuant to Section 186 of the AEA and 10 CFR 110.52.

From the assurances provided to the Commission in the June 16, 1999 meeting, it is the Commission's understanding that ANL will be able to complete a feasibility study promptly, within approximately three months of receiving the necessary technical information. The Commission further understands that AECL will cooperate fully with ANL to complete a feasibility study as soon as possible. Having said this, we recognize that in determining whether changes are feasible, applicants will have to consider the commitments it has made to the Canadian Government and its customers with respect to assuring the supply of medical isotopes and otherwise keeping costs to a minimum.

[ Medical Isotopes and Nuclear Reactors ]

[ AECL's Isotope Business ]

[ Findings on CANDU Safety ]

[ Reactor Accidents Sub-Directory ] [ COMPLETE DIRECTORY ]













Since March 27th 1996, there have been over
100,000 outside visitors to the CCNR web site, plus

(counter reset July 2nd 1998 at midnight)